Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 64Lymphoid 56Gastrointestinal 52CNS 41Head & Neck 35Thoracic 32Breast 31Sarcoma 23Gynecologic 23Plasma cell 19Other hematologic neoplasm 18Dermatologic 16Tumor-Agnostic 10Endocrine 10NET 5Myeloid 5Other solid neoplasm 2Other neoplasm 1Other 1

Conditions

Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Specimen Handling 2radium Ra 223 dichloride 1X-Rays 1Taxes 1Resistance Training 1Photons 1Paclitaxel 1Methods 1Magnetic Resonance Spectroscopy 1Fitness Trackers 1Educational Status 1Early Intervention, Educational 1Chemoradiotherapy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Magnetic Resonance Spectroscopy × Other neoplasm × 30 days × Clear all
NCT04090398 2026-05-13

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

National Cancer Institute (NCI)

Phase 2 Active not recruiting
70 enrolled
BreastOther neoplasm

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡